Who We Are

Partnerships

To advance innovation and our mission to help oncology patients, we collaborate with other industry-leading biotechnology, pharmaceutical, and emerging biotech companies.

Natasha Hernday

Executive Vice President of Corporate Development

In it for life, together

Our partnerships focus on:

  • Innovative in-licensing opportunities at all development stages to diversify and grow our emerging global portfolio
  • Clinical and research collaborations that broaden the potential of our internal programs
  • Novel platform technologies that synergize with or expand our antibody–drug conjugate (ADC) capabilities in new and unique ways

Connect with us

To explore partnership opportunities, please contact businessdevelopment@legalizedancingnyc.com.

Our team

ca888亚洲城 corporate development team

Steven Bartz

Vice President, Corporate Development

ca888亚洲城 corporate development team

Emilie Coueignoux Chen

Sr. Director, Corporate Development

ca888亚洲城 corporate development team

Wesley Galamb

Sr. Director, Corporate Development

ca888亚洲城 corporate development team

Kelly Callahan

Sr. Manager, Corporate Development

ca888亚洲城 corporate development team

Natasha Balakrishna

Sr. Manager, Corporate Development


Our co-development and commercial partners

ca888亚洲城 collaborator Astellas
ca888亚洲城 collaborator Genmab
ca888亚洲城 collaborator Merck
ca888亚洲城 collaborator Takeda
ca888亚洲城 collaborator RemeGen

Our clinical collaborators

ca888亚洲城 collaborator Bristol Myers Squibb
ca888亚洲城 collaborator Genentech
ca888亚洲城 collaborator Merck

Our ADC technology collaborators

ca888亚洲城 collaborator Abbvie
ca888亚洲城 collaborator Genentech
ca888亚洲城 collaborator Genmab
ca888亚洲城 collaborator GlaxoSmithKline
ca888亚洲城 collaborator Lantheus
>